Novartis CEO Says New Purchases Will Boost Sales

April 22 (Bloomberg) -- Novartis AG Chief Executive Officer Joe Jimenez talks about the agreement to buy GlaxoSmithKline Plc’s cancer-drug business for as much as $16 billion, forming a consumer-health venture with Glaxo and selling its animal-health operation to Eli Lilly & Co. for $5.4 billion. He speaks from Basel, Switzerland, with Mark Barton and Anna Edwards on Bloomberg Television's "Countdown." (Source: Bloomberg)

BofAML's Woo Sees Global Synchronized Recovery Roll Over
04:31 - Bank of America Head of Global Rates and FX Research David Woo weighs talks about china and emerging markets. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • Turkey Prime Minister Yildirim on Investment
  • Why Chinese Firms Need More Controls
  • Chinese Consumers Reject Hyundai, Chose Other Car Makers